Can tetrahydroisoquinoline (TIQ) or N-methyl-TIQ produce parkinsonism?

  • M. Yoshida
  • M. Ogawa
  • T. Nagatsu
Conference paper
Part of the Key Topics in Brain Research book series (KEYTOPICS)


We have examined the effect of chronic administration of a probable endogenous dopaminergic neurotoxin, tetrahydroisoquinoline (TIQ, 20mg/kg per day, s.c. for up to 104 days), on squirrel monkeys. Chronically administered TIQ produced motor symptoms similar to parkinsonism in squirrel monkeys even after 7 days’ discontinuation of TIQ and the symptoms were alleviated remarkably by levodopa treatment. Biochemical analysis of the brains of TIQ-treated monkeys revealed significant decrease in dopamine (DA) and total biopterin (BP) concentrations, and tyrosine hydroxylase (TH) activity in the substantia nigra. Morphological changes of the substantia nigra of the mice were also analysed. The effect of long-term administration of N-methyl-TIQ on aged monkeys was described.


Tyrosine Hydroxylase Substantia Nigra Biogenic Amine Squirrel Monkey Motor Disturbance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Kohno M, Ohta S, Hirobe M (1986) Tetrahydroisoquinoline and 1-methyl-tetrahy-droisoquinoline as novel endogenous amines in rat brain. Biochem Biophys Res Commun 140: 448–454PubMedCrossRefGoogle Scholar
  2. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980PubMedCrossRefGoogle Scholar
  3. Makino Y, Ohta S, Tachikawa O, Hirobe M (1988) Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson’s disease. Life Sci 43: 373–378PubMedCrossRefGoogle Scholar
  4. Mori S, Fujitake J, Kuno S, Sano Y (1988) Immunohistochemical evaluation of the neurotoxic effects of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine ( MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci Lett 90: 57–62Google Scholar
  5. Nagatsu I (1983) Immunohistochemistry of biogenic amines and immunoenzyme- histocytochemistry on catecholamine-synthesizing enzymes: application for axoplasmic transport and neuronal localization. In: Methods of biogenic amine research. Elsevier, Amsterdam, pp 873–909Google Scholar
  6. Nagatsu T, Hirata Y (1986) Inhibition of the tyrosine hydroxylase system by MPTP, l-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo. Eur Neurol 26 [Suppl 1]: 11–15CrossRefGoogle Scholar
  7. Nagatsu T, Yoshida M (1988) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178–182PubMedCrossRefGoogle Scholar
  8. Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun 144: 1084–1089PubMedCrossRefGoogle Scholar
  9. Niwa T, Takeda N, Tatematsu A, Matsuura S, Yoshida M, Nagatsu T (1988) Migration of tetrahydroisoquinoline, a possible parkinsonia neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry. J Chromatogr 452: 85 - 91PubMedCrossRefGoogle Scholar
  10. Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T (1989) Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr 493: 345–352Google Scholar
  11. Ogawa M, Araki M, Nagatsu I, Nagatsu T, Yoshida M (1989) The effect of 1,2,3,4- tetrahydroisoquinoline (TIQ) on mesencephalic dopaminergic neurons in C57BL/ 6J mice: immunohistochemical studies-tyrosine hydroxylase. Biogenic Amines 6: 427–436Google Scholar
  12. Ohta S, Kohno K, Makino Y, Tachikawa O, Hirobe M (1987) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinsons disease. Biomed Res 8: 453–456Google Scholar
  13. Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS (1986) Fate of nigrostriatal neurons in young mature mice given l-methyl-4-phenyl-l,2,3,6- tetrahydropyridine: a neurochemical and morphological reassessment. Brain Res 376: 117–124PubMedCrossRefGoogle Scholar
  14. Saitoh T, Niijima K, Mizuno Y (1987) Long-term effect of l-methyl-4-phenyl-l,2,3,6- tetrahydropyridine ( MPTP) on striatal dopamine content in young and mature mice. J Neurol Sci 77: 229–235Google Scholar
  15. Yoshida M, Niwa T, Nagatsu T (1990) Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes. Neurosci Lett 119: 109–113PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • M. Yoshida
    • 1
  • M. Ogawa
    • 1
  • T. Nagatsu
    • 2
  1. 1.Department of NeurologyJichi Medical SchoolTochigikenJapan
  2. 2.Department of BiochemistryNagoya UniversityNagoyaJapan

Personalised recommendations